tetano
Editor, Senior Moderator
Gac Med Mex. 2019;155(5):423-429. doi: 10.24875/GMM.M20000327. [h=1]Clinical-epidemiological profile of deaths from influenza with a history of timely vaccination, Mexico 2010-2018.[/h]
Kuri-Morales PA[SUP]1[/SUP], Castillo-Flores GDD[SUP]2[/SUP], Casta?eda-Prado A[SUP]1[/SUP], Pacheco-Montes SR[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]Introduction:[/h] Influenza epidemics are of higher risk at the extremes of life and in people with comorbidities. Effective vaccination prevents the occurrence of serious cases and decreases mortality.
[h=4]Objective:[/h] To describe deaths from influenza with a history of timely vaccination, from the 2010 to the 2018 season in Mexico.
[h=4]Method:[/h] Cross-sectional, descriptive study where the Influenza Epidemiological Surveillance System database was used.
[h=4]Results:[/h] From 2010 to 2018, 65 vaccinated individuals died from influenza, from which 55% of cases (n = 36) were due to type A (H1N1), 51% (n = 33) were females, median age was 57 years, 21 % (n = 14) did not meet the operational definition of influenza-like illness or severe acute respiratory infection, 83% (n = 54) had at least one comorbidity, with the most common being diabetes mellitus and hypertension (32% each); 55% (n = 36) of deaths received antiviral treatment and only 8% (n = 5) had no comorbidities and received treatment with oseltamivir.
[h=4]Conclusions:[/h] Deaths from influenza with timely vaccination represent a very low percentage of the totality. Vaccination against influenza has been a specific prevention strategy that decreases disease burden.
Copyright: ? 2019 Permanyer.
[h=4]KEYWORDS:[/h] Cause of death; Human influenza; Vaccination
PMID: 32091021 DOI: 10.24875/GMM.M20000327
Kuri-Morales PA[SUP]1[/SUP], Castillo-Flores GDD[SUP]2[/SUP], Casta?eda-Prado A[SUP]1[/SUP], Pacheco-Montes SR[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] [h=4]Introduction:[/h] Influenza epidemics are of higher risk at the extremes of life and in people with comorbidities. Effective vaccination prevents the occurrence of serious cases and decreases mortality.
[h=4]Objective:[/h] To describe deaths from influenza with a history of timely vaccination, from the 2010 to the 2018 season in Mexico.
[h=4]Method:[/h] Cross-sectional, descriptive study where the Influenza Epidemiological Surveillance System database was used.
[h=4]Results:[/h] From 2010 to 2018, 65 vaccinated individuals died from influenza, from which 55% of cases (n = 36) were due to type A (H1N1), 51% (n = 33) were females, median age was 57 years, 21 % (n = 14) did not meet the operational definition of influenza-like illness or severe acute respiratory infection, 83% (n = 54) had at least one comorbidity, with the most common being diabetes mellitus and hypertension (32% each); 55% (n = 36) of deaths received antiviral treatment and only 8% (n = 5) had no comorbidities and received treatment with oseltamivir.
[h=4]Conclusions:[/h] Deaths from influenza with timely vaccination represent a very low percentage of the totality. Vaccination against influenza has been a specific prevention strategy that decreases disease burden.
Copyright: ? 2019 Permanyer.
[h=4]KEYWORDS:[/h] Cause of death; Human influenza; Vaccination
PMID: 32091021 DOI: 10.24875/GMM.M20000327